HGH Holdings Ltd. Announces Extension of Completion Date for Disposal of 20% Stake in Premium Concrete Pte. Ltd.

Key Highlights:

• HGH Holdings Ltd. has entered into a Share Purchase Agreement (SPA) to dispose of 20% of its wholly-owned subsidiary, Premium Concrete Pte. Ltd., to Mr Lim Kui Teng.
• The disposal involves 200,000 issued and paid-up shares in Premium Concrete, representing 20% of the company’s total share capital.
• The aggregate consideration for the sale is S\$2,400,000.
• The completion date for this transaction has been mutually extended to 23 April 2026, beyond the original deadline of 19 March 2026.
• The condition precedent in the SPA has already been satisfied.
• Waiver granted for the resignation of an existing director of Premium Concrete as a completion obligation; all other terms and conditions of the SPA remain unchanged.

Details for Investors:

• The extension of the completion date provides both parties more time to finalize the transaction, which may affect the timing of when HGH Holdings recognizes the proceeds from the sale.
• The S\$2.4 million consideration represents a significant sum for the company, potentially impacting cash flow, net asset value, and future financial statements.
• Premium Concrete is a wholly-owned subsidiary prior to this transaction. Post-disposal, HGH Holdings will retain an 80% stake, which could affect future earnings contributions from Premium Concrete.
• The waiver regarding the director’s resignation may indicate flexibility in management continuity and could signal stability for Premium Concrete post-transaction.
• All other terms of the SPA remain unchanged, ensuring investors that the deal’s fundamental structure is intact.

Potential Price Sensitivity:

• The disposal of a substantial stake in a key subsidiary and the realization of a cash sum may be material to HGH Holdings’ operations and financial health.
• Changes in subsidiary ownership or the injection of proceeds could affect the company’s share value, especially if the market perceives the transaction as unlocking value or improving liquidity.
• The announcement of the extension, along with the satisfaction of all conditions precedent, reduces uncertainty and signals a high probability of completion.
• Shareholders should monitor further announcements for material developments related to the completion or any changes in terms.

Management and Regulatory Details:

• The announcement was made by Tan Poh Guan, Executive Director and CEO, on 16 April 2026.
• The Company’s sponsor, SAC Capital Private Limited, has reviewed the announcement, but the Singapore Exchange Securities Trading Limited (SGX-ST) assumes no responsibility for its contents.
• Contact information for the sponsor is provided, indicating openness and transparency for investor inquiries.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are encouraged to conduct their own research and consult with professional advisors before making any investment decisions. Neither the company nor its sponsor, SAC Capital Private Limited, nor the Singapore Exchange Securities Trading Limited (SGX-ST) assumes any responsibility for the accuracy of the information or for any investment actions taken based on this announcement.

View HGH Historical chart here